Ownership

Wei Lin

Insider Reports History

Entity: Individual
Location: C/O Erasca, Inc., 10835 Road To The Cure, Suite 140, San Diego, CA
Signature: /s/ Jack Anders, as Attorney-in-fact for Wei Lin
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wei Lin:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Revolution Medicines, Inc.	Chief Medical Officer	Common Stock	91.7K	$3.71M	$40.50	Mar 1, 2025	Direct
Erasca, Inc.	Chief Medical Officer	Common Stock	316K	$502K	$1.59	Feb 1, 2023	Direct
2seventy bio, Inc.	Director	Common Stock	32.9K	$137K	$4.18	Jun 10, 2024	Direct
2seventy bio, Inc.	Director	Stock Options (Right to buy)	24.1K	$94.7K	$3.93	Jun 10, 2024	Direct
Erasca, Inc.	Chief Medical Officer	Stock Option (right to buy)	560K			Feb 1, 2023	Direct
Revolution Medicines, Inc.	Chief Medical Officer	Stock Option (Right to Buy)	72.8K			Mar 1, 2025	Direct

Showing 1 to 6 of 6 entries

Insider Reports Filed by Wei Lin

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
RVMD	Revolution Medicines, Inc.	Mar 1, 2025	2	$0	4	Mar 4, 2025	Chief Medical Officer
RVMD	Revolution Medicines, Inc.	Jun 17, 2024	1	-$209K	4	Jun 20, 2024	Chief Medical Officer
TSVT	2seventy bio, Inc.	Jun 10, 2024	2	$0	4	Jun 12, 2024	Director
RVMD	Revolution Medicines, Inc.	Mar 21, 2024	0	$0	3	Mar 29, 2024	Chief Medical Officer
TSVT	2seventy bio, Inc.	Jun 13, 2023	2	$0	4	Jun 15, 2023	Director
TSVT	2seventy bio, Inc.	Mar 7, 2023	2	$0	4	Mar 9, 2023	Director
TSVT	2seventy bio, Inc.	Mar 7, 2023	0	$0	3	Mar 9, 2023	Director
ERAS	Erasca, Inc.	Feb 1, 2023	3	$7.17K	4	Feb 3, 2023	Chief Medical Officer
ERAS	Erasca, Inc.	Feb 1, 2022	2	$18.1K	4	Feb 3, 2022	Chief Medical Officer
ERAS	Erasca, Inc.	Jul 15, 2021	0	$0	3	Jul 15, 2021	Chief Medical Officer